Bellevue Group AG

Q4 2024 13F-HR Holdings

Location
Kuesnacht, V8
Holdings as of
12/31/2024
Date filed
2/14/2025
Form type
13F-HR
Num holdings
161
Total value ($000)
$5,195,082
Net value change ($000)
-977,546 (-15.8%)
New positions
12
Sold out positions
14
Turnover %
4.2%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 11/14/2024 Next filing: 5/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q3 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
SRRK 91,201 526.8%
NBIX 33,683 15.7%
Intra-Cellular Therapies, Inc. 21,936 12.1%
ARGX 21,764 6.3%
MRK 21,489 448.1%
BRKR 21,079 NEW
WAVE LIFE SCIENCES LTD 17,073 50.9%
EHC 15,551 836.5%
AMGN 15,156 187.0%
DXCM 13,091 19.2%
Top Reduces (Value $000, Stocks/ETFs)
VRTX -69,460 -26.1%
CDNA -68,791 -70.0%
EVH -62,980 -83.4%
EXAS -59,739 -60.5%
OPCH -51,798 -100.0%
UNH -51,083 -38.7%
AGIO -50,479 -30.4%
TNDM -50,312 -64.1%
EPIX -47,750 -100.0%
EXEL -41,520 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 110 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type